References
Arango, D., Sturgill, D., Alhusaini, N., Dillman, A.A., Sweet, T.J., Hanson, G., Hosogane, M., Sinclair, W. R., Nanan, K.K., Mandler, M.D., et al. (2018). Acetylation of cytidine in mRNA promotes translation efficiency. Cell 175, 1872–1886.
Arango, D., Sturgill, D., Yang, R., Kanai, T., Bauer, P., Roy, J., Wang, Z., Hosogane, M., Schiffers, S., and Oberdoerffer, S. (2022). Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell 82, 2912.
Dalhat, M.H., Mohammed, M.R.S., Alkhatabi, H.A., Rehan, M., Ahmad, A., Choudhry, H., and Khan, M. I. (2022). NAT10: an RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clin Transl Med 12, e1045.
Dominissini, D., and Rechavi, G. (2018). N4-acetylation of cytidine in mRNA by NAT10 regulates stability and translation. Cell 175, 1725–1727.
Jin, G., Xu, M., Zou, M., and Duan, S. (2020). The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol Ther Nucleic Acids 20, 13–24.
Liu, H.Y., Liu, Y.Y., Yang, F., Zhang, L., Zhang, F.L., Hu, X., Shao, Z.M., and Li, D.Q. (2020). Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res 48, 3638–3656.
Liao, L., He, Y., Li, S.J., Yu, X.M., Liu, Z.C., Liang, Y.Y., Yang, H., Yang, J., Zhang, G.G., Deng, C.M., et al. (2023). Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res 33, 355–371.
Sharma, S., Langhendries, J.L., Watzinger, P., Kötter, P., Entian, K.D., and Lafontaine, D.L.J. (2015). Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1/THUMPD1. Nucleic Acids Res 43, 2242–2258.
Wang, G., Zhang, M., Zhang, Y., Xie, Y., Zou, J., Zhong, J., Zheng, Z., Zhou, X., Zheng, Y., Chen, B., et al. (2022). NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med 12, e738.
Whipple, J.M., Lane, E.A., Chernyakov, I., D’Silva, S., and Phizicky, E.M. (2011). The yeast rapid tRNA decay pathway primarily monitors the structural integrity of the acceptor and T-stems of mature tRNA. Genes Dev 25, 1173–1184.
Xie, L., Zhong, X., Cao, W., Liu, J., Zu, X., and Chen, L. (2023a). Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids 32, 359–368.
Xie, R., Cheng, L., Huang, M., Huang, L., Chen, Z., Zhang, Q., Li, H., Lu, J., Wang, H., Zhou, Q., et al. (2023b). NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res 83, 1666–1683.
Yankova, E., Blackaby, W., Albertella, M., Rak, J., De Braekeleer, E., Tsagkogeorga, G., Pilka, E.S., Aspris, D., Leggate, D., Hendrick, A.G., et al. (2021). Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597–601.
Zhang, Y., Jing, Y., Wang, Y., Tang, J., Zhu, X., Jin, W. L., Wang, Y., Yuan, W., Li, X., and Li, X. (2021). NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Sig Transduct Target Ther 6, 173.
Zheng, X., Wang, Q., Zhou, Y., Zhang, D., Geng, Y., Hu, W., Wu, C., Shi, Y., and Jiang, J. (2022). N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun 42, 1347–1366.
Acknowledgement
This work was supported by the National Key Research and Development Program of China (2022YFC2601800), the National Natural Science Foundation of China (32161143017, 82173833, 82173126, 82372743, 81973343), the Guangdong Basic and Applied Basic Research Foundation (2023B1515040006, 2022A1515011632), Science and Technology Planning Project of Guangdong Province, China (2022A0505050065), the Open Program of Shenzhen Bay Laboratory (SZBL202009051006) and the Guangdong Provincial Key Laboratory of Construction Foundation (2023B1212060022).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The author(s) declare that they have no conflict of Interest.
Rights and permissions
About this article
Cite this article
Tao, L., Lu, Y., Chen, Z. et al. RNA ac4C modification in cancer biology: from regulatory mechanisms to clinical applications. Sci. China Life Sci. 67, 832–835 (2024). https://doi.org/10.1007/s11427-023-2496-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-023-2496-5